Search results
New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
Medical Xpress· 3 days agoA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of ...
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and—...
Newswise· 5 days agoA new study led by University of Michigan Health Rogel Cancer Center researchers identifies novel...
Plasma proteome profiling reveals dynamic of cholesterol marker after dual blocker therapy - Nature...
Nature· 3 days agoDual blockade therapy is currently being trialled for multiple tumour types, but efficacy is variable. Here, the authors use longitudinal proteomics profiling of 22 patients to develop a predictive model of therapy response.
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 18 hours agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoWe'd also like to congratulate ArsenalBio, who in April announced the first patient dosed in a Phase...
Good to Know: Grim diagnosis spurs Kent couple to sell possessions, plan RV trip of a lifetime
Akron Beacon Journal· 5 days agoPlan B moves to the top of the list for Mark Dailey and Melissa Cairns after cancer diagnosis. The...
Nexavar Dosage: Form, Strength, How to Take, and More
Healthline· 5 days agoNexavar (sorafenib) is a prescription drug used to treat liver, kidney, and thyroid cancers. Nexavar belongs to a group of drugs called kinase inhibitors and contains the active ingredient sorafenib ...
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoCytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript May 8, 2024 CytomX...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
Forbes· 5 days agoThis article is part of an ongoing series on novel cancer advances, including immunotherapies such...